Christopher Smith
2021 - Ortho Clinical Diagnostics Holdings plc
In 2021, Christopher Smith earned a total compensation of $6.2M as Chairman and Chief Executive Officer at Ortho Clinical Diagnostics Holdings plc.
Compensation breakdown
| Bonus | $2,000,250 |
|---|---|
| Non-Equity Incentive Plan | $1,326,312 |
| Salary | $1,250,000 |
| Stock Awards | $1,500,000 |
| Other | $121,134 |
| Total | $6,197,696 |
Smith received $2M in bonus, accounting for 32% of the total pay in 2021.
Smith also received $1.3M in non-equity incentive plan, $1.3M in salary, $1.5M in stock awards and $121.1K in other compensation.
Rankings
In 2021, Christopher Smith's compensation ranked 2,045th out of 12,406 executives tracked by ExecPay. In other words, Smith earned more than 83.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,045 out of 12,406 | 84th |
Division Manufacturing | 784 out of 5,492 | 86th |
Major group Chemicals And Allied Products | 305 out of 2,368 | 87th |
Industry group Drugs | 264 out of 2,089 | 87th |
Industry In Vitro and In Vivo Diagnostic Substances | 3 out of 61 | 95th |
Source: SEC filing on May 2, 2022.
Smith's colleagues
We found four more compensation records of executives who worked with Christopher Smith at Ortho Clinical Diagnostics Holdings plc in 2021.
2021
Michael Iskra
Ortho Clinical Diagnostics Holdings plc
Executive Vice President, Strategy & Commercial Excellence
2021
Michael Schlesinger
Ortho Clinical Diagnostics Holdings plc
General Counsel
2021
Joseph Busky
Ortho Clinical Diagnostics Holdings plc
Chief Financial Officer
2021
Chockalingam Palaniappan
Ortho Clinical Diagnostics Holdings plc